Activating the WNT/Β-Catenin Pathway for the Treatment of Melanoma – Application of LY2090314, a Novel Selective Inhibitor of Glycogen Synthase Kinase-3

PLoS ONE - United States
doi 10.1371/journal.pone.0125028
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Drug Development Targeting the Glycogen Synthase Kinase-3β (GSK-3β)-Mediated Signal Transduction Pathway: Inhibitors of the WNT/Β-Catenin Signaling Pathway as Novel Anticancer Drugs

Journal of Pharmacological Sciences
Molecular MedicinePharmacology
2009English

Loss of Expression for the WNT Pathway Components Adenomatous Polyposis Coli and Glycogen Synthase Kinase 3-Β in Parathyroid Carcinomas

International Journal of Oncology
Cancer ResearchOncology
1992English

Hydrosulfide Attenuates Acute Myocardial Ischemic Injury Through the Glycogen Synthase Kinase-3β/Β-Catenin Signaling Pathway

International Journal of Molecular Medicine
MedicineGenetics
2016English

Glycogen Synthase Kinase 3-Β Inhibition Induces Lymphangiogenesis Through Β-Catenin-Dependent and mTOR-independent Pathways

PLoS ONE
Multidisciplinary
2019English

Role of the WNT-Β-Catenin Signaling Pathway in Melanoma-Mediated Dendritic Cell Tolerization

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

Efficacy of Glycogen Synthase Kinase-3β Targeting Against Osteosarcoma via Activation of Β-Catenin

Oncotarget
Oncology
2016English

Glycogen Synthase Kinase-3

International Journal of Alzheimer's Disease
AgingCognitive NeuroscienceMolecular NeuroscienceNeurologyBehavioral NeuroscienceCellular
2011English

Enantioselective Synthesis of the Novel Chiral Sulfoxide Derivative as a Glycogen Synthase Kinase 3β Inhibitor

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
2010English

WNT/Β-Catenin Inhibitor Dickkopf 1

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy